◆英語タイトル:Cytori Therapeutics Inc (CYTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013841
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月22日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Cytori Therapeutics Inc (Cytori) is a clinical stage regenerative medicine company. It develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two therapeutic development platforms namely, Cytori Cell Therapy (CCT) and Cytori Nanomedicine. Cytori uses CCT platform based on the scientific discovery to develop variety of therapies with focus on the treatment of impaired hand function in scleroderma. The Cytori Nanomedicine is a versatile and novel protein-stabilized liposomal nanoparticle technology used for drug encapsulation. The company offers its products to the physicians, researchers, hospitals, clinics and other customers for commercial and research purposes. Cytori is headquartered in San Diego, California, the US.
Cytori Therapeutics Inc (CYTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cytori Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cytori Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cytori Therapeutics Inc, Medical Equipment, Deal Details 11
Partnerships 11
Human Stem Cells Institute Enters into Co-Marketing Agreement with Cytori Therapeutics for Celution System 11
Lorem Vascular Amends Licensing Agreement with Cytori Therapeutics 12
Cytori Therapeutics Enters Into Licensing Agreement With Bimini Technologies For Celution 13
Equity Offering 14
Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares 14
Cytori Therapeutics Raises USD20 Million in Private Placement of Shares 15
Cytori Therapeutics Raises USD2.5 Million in Second and Final Tranche of Private Placement of Units 16
Cytori Therapeutics Raises Funds in First Tranche of Private Placement of Units 18
Cytori Therapeutics Raises USD10 Million in Private Placement of Units 20
Cytori Therapeutics Completes Public Offering Of Shares For US$23 Million 22
Cytori Therapeutics Completes Private Placement Of Shares For US$18.2 Million 23
Asset Transactions 25
Bimini Technologies Acquires Puregraft Rights From Cytori Therapeutics For Up To US$15 Million 25
Acquisition 26
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 26
Cytori Therapeutics Inc – Key Competitors 27
Cytori Therapeutics Inc – Key Employees 28
Cytori Therapeutics Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 09, 2017: Cytori Reports Third Quarter 2017 Business and Financial Results 30
Aug 10, 2017: Cytori Reports Second Quarter 2017 Business and Financial Results 31
May 11, 2017: Cytori Reports First Quarter 2017 Business and Financial Results 32
Mar 23, 2017: Cytori Reports Fourth Quarter and Full Year 2016 Business and Financial Results 33
Nov 09, 2016: Cytori Reports Third Quarter 2016 Business and Financial Results 34
Aug 04, 2016: Cytori Reports Second Quarter 2016 Business and Financial Results 35
May 10, 2016: Cytori Reports First Quarter 2016 Business and Financial Results 37
Mar 03, 2016: Cytori Reports Fourth Quarter and Full Year 2015 Business and Financial Results 38
Corporate Communications 39
Apr 03, 2017: Cytori Appoints Gregg Lapointe to Board of Directors 39
Dec 28, 2016: Ronald Martell to Join Cytori Therapeutics’ Board of Directors 40
Product News 41
Jun 01, 2017: Cytori to Introduce Next-Generation Celution® Technology 41
Jun 08, 2016: Presentation of Twelve Month Pilot Trial Data of Cytori Cell Therapy for ACL Reconstruction 42
Feb 08, 2016: Cytori Reports Interim Data on U.S. Phase II Osteoarthritis Trial 43
Other Significant Developments 44
Jun 08, 2017: Long Term Safety Data Published on Cytori Technology for Breast Reconstruction After Oncologic Surgery & Radiation Therapy 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
List of Tables
Cytori Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cytori Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cytori Therapeutics Inc, Deals By Market, 2011 to YTD 2017 9
Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Human Stem Cells Institute Enters into Co-Marketing Agreement with Cytori Therapeutics for Celution System 11
Lorem Vascular Amends Licensing Agreement with Cytori Therapeutics 12
Cytori Therapeutics Enters Into Licensing Agreement With Bimini Technologies For Celution 13
Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares 14
Cytori Therapeutics Raises USD20 Million in Private Placement of Shares 15
Cytori Therapeutics Raises USD2.5 Million in Second and Final Tranche of Private Placement of Units 16
Cytori Therapeutics Raises Funds in First Tranche of Private Placement of Units 18
Cytori Therapeutics Raises USD10 Million in Private Placement of Units 20
Cytori Therapeutics Completes Public Offering Of Shares For US$23 Million 22
Cytori Therapeutics Completes Private Placement Of Shares For US$18.2 Million 23
Bimini Technologies Acquires Puregraft Rights From Cytori Therapeutics For Up To US$15 Million 25
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 26
Cytori Therapeutics Inc, Key Competitors 27
Cytori Therapeutics Inc, Key Employees 28
Cytori Therapeutics Inc, Other Locations 29
Cytori Therapeutics Inc, Subsidiaries 29